Skip to main content

Table 1 Number of cases of bowel perforation following treatment with carboplatin and paclitaxel in the literature

From: Rectal perforation following paclitaxel and carboplatin chemotherapy for advanced ovarian cancer: a case report and review of the literature

Author(s) and reference number Title of article Type of cancer Journal Volume Year Number of cases reported
Samejima et al. [8] Rectal perforation in a patient treated with combination chemotherapy for lung cancer Lung cancer Gan To Kagaku Ryoho 36(2):301–4 2009 1
de Haan and van den Berg [4] Colonic perforation secondary to taxol therapy: an unusual presentation Ovarian cancer Onkologie 29(11):541–2 2006 1
Rose and Piver [5] Intestinal perforation secondary to paclitaxel Ovarian cancer Gynecologic Oncology 57(2):270–2 1995 3
Seewaldt et al. [10] Paclitaxel (Taxol) treatment for refractory ovarian cancer: phase II clinical trial Ovarian cancer Am J Obstet Gynecol 170(6):1666–70 1994 4
Carter and Durfee [7] A case of bowel perforation after neoadjuvant chemotherapy for advanced epithelial ovarian cancer Ovarian cancer Gynecologic Oncology 107(3):586–9 2007 1
  1. Table 1 indicates the number of cases of colonic perforation mentioned in the literature following treatment with paclitaxel. It indicates the type of malignancy being treated and the total number of cases detected. The journals found include non-English journals